Erik Atkisson
Compliance Officer at RAIN ONCOLOGY INC.
Net worth: 1 001 $ as of 2024-03-30
Profile
Erik Atkisson is currently the General Counsel & Chief Compliance Officer at Rain Oncology, Inc. Prior to this, he was the Chief Compliance Officer at Cytokinetics, Inc. He also served as the Secretary & General Counsel at Eiger BioPharmaceuticals, Inc. from 2021 to 2023.
Mr. Atkisson received his undergraduate degree from Harvard University, his graduate degree from The University of Edinburgh, and his law degree from Georgetown University Law Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-01-25 | 200 ( 0.01% ) | 1 001 $ | 2024-03-30 |
Erik Atkisson active positions
| Companies | Position | Start |
|---|---|---|
| RAIN ONCOLOGY INC. | Compliance Officer | - |
Former positions of Erik Atkisson
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 2023-04-12 |
| CYTOKINETICS, INCORPORATED | Compliance Officer | - |
Training of Erik Atkisson
| Harvard University | Undergraduate Degree |
| The University of Edinburgh | Graduate Degree |
| Georgetown University Law Center | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
- Stock Market
- Insiders
- Erik Atkisson
